S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
New CBOE “special perk” helps traders target income every weekend (Ad)
3 reasons to buy AMD before 2024
How does the Consumer Price Index affect the stock market?
New CBOE “special perk” helps traders target income every weekend (Ad)
3 biotech powerhouses poised to thrive amid sector rebound
Broadcom falls into a buy-the-dip opportunity 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
A 'soft landing' or a recession? How each one might affect America's households and businesses
Closing prices for crude oil, gold and other commodities
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
New CBOE “special perk” helps traders target income every weekend (Ad)
3 reasons to buy AMD before 2024
How does the Consumer Price Index affect the stock market?
New CBOE “special perk” helps traders target income every weekend (Ad)
3 biotech powerhouses poised to thrive amid sector rebound
Broadcom falls into a buy-the-dip opportunity 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
A 'soft landing' or a recession? How each one might affect America's households and businesses
Closing prices for crude oil, gold and other commodities
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
New CBOE “special perk” helps traders target income every weekend (Ad)
3 reasons to buy AMD before 2024
How does the Consumer Price Index affect the stock market?
New CBOE “special perk” helps traders target income every weekend (Ad)
3 biotech powerhouses poised to thrive amid sector rebound
Broadcom falls into a buy-the-dip opportunity 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
A 'soft landing' or a recession? How each one might affect America's households and businesses
Closing prices for crude oil, gold and other commodities
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
New CBOE “special perk” helps traders target income every weekend (Ad)
3 reasons to buy AMD before 2024
How does the Consumer Price Index affect the stock market?
New CBOE “special perk” helps traders target income every weekend (Ad)
3 biotech powerhouses poised to thrive amid sector rebound
Broadcom falls into a buy-the-dip opportunity 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
A 'soft landing' or a recession? How each one might affect America's households and businesses
Closing prices for crude oil, gold and other commodities

VanEck Biotech ETF (BBH) Price, Holdings, & News

$153.96
-1.28 (-0.82%)
(As of 12/8/2023 ET)
Compare
Today's Range
$153.91
$155.17
50-Day Range
$143.93
$159.18
52-Week Range
$142.51
$170.25
Volume
9,761 shs
Average Volume
11,690 shs
Market Capitalization
$449.56 million
Assets Under Management
$456.88 million
Dividend Yield
0.49%
Net Expense Ratio
0.35%
BBH stock logo

About VanEck Biotech ETF (NASDAQ:BBH)

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.

BBH Stock Price History

BBH ETF News Headlines

BBH ETF Stock Price History
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
VanEck ETFs
Van Eck Biotech Etf $BBH Trading Report
BBH VanEck Biotech ETF
All the trading advice you’ve ever received boils down to this
All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.
See More Headlines
Receive BBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VanEck Biotech ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
Van Eck
Fund Name
VanEck Biotech ETF
Tax Classification
Regulated Investment Company
Current Symbol
NASDAQ:BBH
Inception Date
12/20/2011
Fund Manager
Hao-Hung Peter Liao, Guo Hua Jason Jin
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
Market Vectors US Listed Biotech 25 Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
Global
Number of Holdings
25

Fund Statistics

Assets Under Management
$456.88 million
Average Daily Volume
$12,086.70
Discount/Premium
0.18%

Administrator, Advisor and Custodian

Administrator
Van Eck Associates Corporation
Advisor
Van Eck Associates Corporation
Custodian
State Street Bank and Trust Company
Distributor
Van Eck Securities Corporation
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
Optionable
Options Volume
9
Put Options
1
Call Options
8
Short Interest
7,600 shs

Miscellaneous

Beta
0.79
Creation Unit
50,000
Creation Fee
$500.00
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

VanEck Biotech ETF Expenses

TypeBBHHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.35%0.56%0.53%0.47%0.51%
Other Expenses0.00%0.40%0.54%0.29%0.57%
Total Expense0.35%0.72%0.70%0.56%0.70%
Fee Waiver0.00%-0.51%-0.54%-0.21%-0.58%
Net Expense0.35%0.61%0.60%0.52%0.57%

VanEck Biotech ETF (BBH) Holdings & Exposure

BBH Sector Exposure

BBH Industry Exposure















BBH ETF - Frequently Asked Questions

How have BBH shares performed in 2023?

VanEck Biotech ETF's stock was trading at $159.74 at the beginning of 2023. Since then, BBH stock has decreased by 3.6% and is now trading at $153.96.
View the best growth stocks for 2023 here
.

Are investors shorting VanEck Biotech ETF?

VanEck Biotech ETF saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 7,600 shares, an increase of 7.0% from the October 31st total of 7,100 shares. Based on an average daily trading volume, of 7,700 shares, the short-interest ratio is presently 1.0 days.
View VanEck Biotech ETF's Short Interest
.

How often does VanEck Biotech ETF pay dividends? What is the dividend yield for VanEck Biotech ETF?

VanEck Biotech ETF announced an annual dividend on Friday, December 16th. Stockholders of record on Tuesday, December 20th will be paid a dividend of $0.749 per share on Friday, December 23rd. This represents a dividend yield of 0.47%. The ex-dividend date is Monday, December 19th. This is a boost from the stock's previous annual dividend of $0.40.
Read our dividend analysis for BBH
.

What does BBH invest in?

VanEck Biotech ETF is a equity fund issued by Van Eck. BBH focuses on health care investments and follows the Market Vectors US Listed Biotech 25 Index. The fund's investments total to approximately $456.88 million assets under management.

What stocks does VanEck Biotech ETF hold?
What is the management fee for VanEck Biotech ETF?

VanEck Biotech ETF's management fee is 0.35% and has no other recorded expenses or fee waivers. The net expense ratio for BBH is 0.35%.

What other stocks do shareholders of VanEck Biotech ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Biotech ETF investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pfizer (PFE), Intel (INTC), Micron Technology (MU), Cidara Therapeutics (CDTX), Quest Diagnostics (DGX), Novavax (NVAX).

Who are VanEck Biotech ETF's major shareholders?

VanEck Biotech ETF's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Miller Investment Management LP (6.12%), JPMorgan Chase & Co. (2.07%), LPL Financial LLC (1.49%), Commonwealth Equity Services LLC (0.99%), UBS Group AG (0.94%) and Royal Bank of Canada (0.86%).

How do I buy shares of VanEck Biotech ETF?

Shares of BBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:BBH) was last updated on 12/9/2023 by MarketBeat.com Staff

My Account -